Investing
BROS, BETZ and DNA: The Race to Claim a Good Ticker and Attract Investors
For newly public companies and funds, a cute or memorable ticker can be key to attracting buyers
A woman holds the ticker tape for a record one million share trade on the New York Stock Exchange in 1967.
Source: Bettmann/Getty ImagesThis article is for subscribers only.
One of the most buzz-worthy tickers in biotech will make its return after a decade-long hiatus.
Ginkgo Bioworks Inc. is set to begin trading under the ticker DNA on Sept. 17 after completing a reverse merger with Soaring Eagle Acquisition Corp. That will mark the first time any company has traded under DNA since 2009, when Roche Holding AG bought Genentech Inc., one of the world’s first biotech firms and the original holder of the ticker.